End-of-day quote
NORDIC GROWTH MARKET
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
0.0188
SEK
|
+9.30%
|
|
-6.00%
|
-43.03%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
80.77
|
31.42
|
77.15
|
113.2
|
104.2
|
39.75
|
Enterprise Value (EV)
1 |
64.33
|
20.46
|
58.03
|
107.4
|
91.55
|
29.1
|
P/E ratio
|
-5.8
x
|
-2.8
x
|
-6.37
x
|
-8.33
x
|
-6.37
x
|
-2.58
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
12,049,122,316
x
|
66,131,399
x
|
233,090,864
x
|
97,378,724
x
|
19,239,490
x
|
EV / Revenue
|
-
|
7,844,513,804
x
|
49,744,103
x
|
221,108,875
x
|
85,575,006
x
|
14,085,434
x
|
EV / EBITDA
|
-3.52
x
|
-1.33
x
|
-4.85
x
|
-8
x
|
-5.71
x
|
-2.07
x
|
EV / FCF
|
-7.57
x
|
-1.7
x
|
-9.48
x
|
-13
x
|
-8.7
x
|
-2.5
x
|
FCF Yield
|
-13.2%
|
-58.9%
|
-10.5%
|
-7.71%
|
-11.5%
|
-39.9%
|
Price to Book
|
5.96
x
|
2.95
x
|
3.56
x
|
13.9
x
|
6.83
x
|
2.61
x
|
Nbr of stocks (in thousands)
|
84,131
|
112,229
|
221,069
|
221,069
|
290,198
|
509,651
|
Reference price
2 |
0.9600
|
0.2800
|
0.3490
|
0.5120
|
0.3590
|
0.0780
|
Announcement Date
|
3/29/18
|
3/20/19
|
2/29/20
|
4/6/21
|
3/1/22
|
3/29/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
0.002608
|
1.167
|
0.4856
|
1.07
|
2.066
|
EBITDA
1 |
-18.28
|
-15.41
|
-11.96
|
-13.41
|
-16.05
|
-14.09
|
EBIT
1 |
-18.34
|
-15.46
|
-12.11
|
-13.58
|
-16.34
|
-15.35
|
Operating Margin
|
-
|
-592,783.7%
|
-1,037.7%
|
-2,795.86%
|
-1,527.73%
|
-743.02%
|
Earnings before Tax (EBT)
1 |
-18.59
|
-15.5
|
-12.12
|
-13.59
|
-16.36
|
-15.41
|
Net income
1 |
-18.59
|
-15.5
|
-12.12
|
-13.59
|
-16.36
|
-15.41
|
Net margin
|
-
|
-594,485.58%
|
-1,038.71%
|
-2,798.32%
|
-1,529.45%
|
-745.73%
|
EPS
2 |
-0.1656
|
-0.1000
|
-0.0548
|
-0.0615
|
-0.0564
|
-0.0302
|
Free Cash Flow
1 |
-8.501
|
-12.04
|
-6.123
|
-8.274
|
-10.52
|
-11.62
|
FCF margin
|
-
|
-461,767.68%
|
-524.79%
|
-1,703.98%
|
-983.61%
|
-562.57%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/18
|
3/20/19
|
2/29/20
|
4/6/21
|
3/1/22
|
3/29/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
16.4
|
11
|
19.1
|
5.82
|
12.6
|
10.6
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-8.5
|
-12
|
-6.12
|
-8.27
|
-10.5
|
-11.6
|
ROE (net income / shareholders' equity)
|
-116%
|
-93.9%
|
-66.2%
|
-91.2%
|
-140%
|
-101%
|
ROA (Net income/ Total Assets)
|
-59.7%
|
-50.1%
|
-38.7%
|
-50.7%
|
-72.6%
|
-53.7%
|
Assets
1 |
31.16
|
30.97
|
31.34
|
26.78
|
22.53
|
28.7
|
Book Value Per Share
2 |
0.1600
|
0.0900
|
0.1000
|
0.0400
|
0.0500
|
0.0300
|
Cash Flow per Share
2 |
0.1500
|
0.0700
|
0.0900
|
0.0300
|
0.0400
|
0.0200
|
Capex
|
-
|
-
|
0.51
|
0.29
|
0.64
|
3.44
|
Capex / Sales
|
-
|
-
|
43.71%
|
58.91%
|
59.46%
|
166.44%
|
Announcement Date
|
3/29/18
|
3/20/19
|
2/29/20
|
4/6/21
|
3/1/22
|
3/29/23
|
|
1st Jan change
|
Capi.
|
---|
| -43.03% | 1.73M | | +73.24% | 12.42B | | -19.09% | 7.81B | | +5.88% | 6.4B | | +13.24% | 5.45B | | +38.48% | 5.01B | | -17.30% | 4.84B | | -19.78% | 4.19B | | -29.53% | 2.69B | | +47.29% | 2.39B |
Medical Equipment
|